A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19

NCT05981846 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

279

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS CoV 2 Infection
Influenza, Human

Interventions

BIOLOGICAL: BIMERVAX
BIOLOGICAL: SIIV

Sponsor

Hipra Scientific, S.L.U